MC

Muhlenkamp & Co Portfolio holdings

AUM $320M
This Quarter Return
+23.26%
1 Year Return
+26.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$248M
AUM Growth
+$248M
Cap. Flow
+$30.6M
Cap. Flow %
12.32%
Top 10 Hldgs %
45.77%
Holding
38
New
5
Increased
26
Reduced
4
Closed
1

Top Buys

1
WCC icon
WESCO International
WCC
$10.3M
2
BIDU icon
Baidu
BIDU
$5.85M
3
RUSHA icon
Rush Enterprises Class A
RUSHA
$5.15M
4
KEX icon
Kirby Corp
KEX
$4.06M
5
SLB icon
Schlumberger
SLB
$3.92M

Top Sells

1
GLD icon
SPDR Gold Trust
GLD
$3.94M
2
GMLP
Golar LNG Partners LP
GMLP
$91K
3
MCHP icon
Microchip Technology
MCHP
$54.4K
4
PFE icon
Pfizer
PFE
$1.03K
5
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$410

Sector Composition

1 Healthcare 21.2%
2 Technology 18.12%
3 Industrials 16.51%
4 Consumer Discretionary 14.65%
5 Financials 10.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BIIB icon
26
Biogen
BIIB
$19.4B
$4.44M 1.79% 18,147 +94 +0.5% +$23K
WAB icon
27
Wabtec
WAB
$33.1B
$4.02M 1.62% 54,964 +771 +1% +$56.4K
SLB icon
28
Schlumberger
SLB
$55B
$3.92M 1.58% +179,410 New +$3.92M
GILD icon
29
Gilead Sciences
GILD
$140B
$2.96M 1.19% 50,803 +643 +1% +$37.5K
FNV icon
30
Franco-Nevada
FNV
$36.3B
$2.18M 0.88% +17,368 New +$2.18M
RGLD icon
31
Royal Gold
RGLD
$11.8B
$2.12M 0.85% +19,924 New +$2.12M
PFE icon
32
Pfizer
PFE
$141B
$874K 0.35% 23,739 -28 -0.1% -$1.03K
MS icon
33
Morgan Stanley
MS
$240B
$740K 0.3% 10,805 – –
CTSH icon
34
Cognizant
CTSH
$35.3B
$737K 0.3% 8,998 +992 +12% +$81.3K
EPD icon
35
Enterprise Products Partners
EPD
$69.6B
$487K 0.2% 24,855 – –
RUSHB icon
36
Rush Enterprises Class B
RUSHB
$4.52B
$254K 0.1% 6,694 +2,109 +46% +$80K
BMY.RT
37
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$48K 0.02% 69,403 -593 -0.8% -$410
GMLP
38
DELISTED
Golar LNG Partners LP
GMLP
– – -44,960 Closed -$91K
1
2